Paloma Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Buy |
+12,557
| New | +$496K | 0.07% | 80 |
|
|
2024
Q2 | – | Sell |
-4,909
| Closed | -$213K | – | 891 |
|
|
2024
Q1 | $213K | Buy |
+4,909
| New | +$213K | 0.01% | 358 |
|
|
2020
Q4 | – | Sell |
-73,486
| Closed | -$3.49M | – | 1671 |
|
|
2020
Q3 | $3.49M | Buy |
73,486
+66,211
| +910% | +$3.14M | 0.09% | 172 |
|
|
2020
Q2 | $429K | Buy |
+7,275
| New | +$429K | 0.01% | 1163 |
|
|
2019
Q1 | – | Sell |
-57,040
| Closed | -$3.08M | – | 1428 |
|
|
2018
Q4 | $3.08M | Buy |
+57,040
| New | +$3.08M | 0.09% | 125 |
|
|
2017
Q4 | – | Sell |
-16,433
| Closed | -$834K | – | 1429 |
|
|
2017
Q3 | $834K | Sell |
16,433
-12,067
| -42% | -$612K | 0.01% | 735 |
|
|
2017
Q2 | $1.45M | Buy |
28,500
+9,149
| +47% | +$465K | 0.02% | 585 |
|
|
2017
Q1 | $778K | Sell |
19,351
-2,755
| -12% | -$111K | 0.01% | 952 |
|
|
2016
Q4 | $1.06M | Buy |
+22,106
| New | +$1.06M | 0.01% | 760 |
|
|
2016
Q1 | – | Sell |
-64,225
| Closed | -$3.98M | – | 1544 |
|
|
2015
Q4 | $3.98M | Buy |
64,225
+57,417
| +843% | +$3.56M | 0.11% | 104 |
|
|
2015
Q3 | $275K | Sell |
6,808
-143,398
| -95% | -$5.79M | 0.01% | 1007 |
|
|
2015
Q2 | $8.65M | Buy |
150,206
+137,046
| +1,041% | +$7.89M | 0.17% | 60 |
|
|
2015
Q1 | $838K | Buy |
13,160
+9,834
| +296% | +$626K | 0.02% | 478 |
|
|
2014
Q4 | $205K | Buy |
+3,326
| New | +$205K | 0.01% | 907 |
|
|
2014
Q3 | – | Sell |
-75,000
| Closed | -$2.58M | – | 1073 |
|
|
2014
Q2 | $2.58M | Buy |
75,000
+4,921
| +7% | +$170K | 0.11% | 153 |
|
|
2014
Q1 | $3.03M | Buy |
70,079
+20,079
| +40% | +$868K | 0.2% | 89 |
|
|
2013
Q4 | $1.99M | Buy |
50,000
+18,500
| +59% | +$737K | 0.1% | 197 |
|
|
2013
Q3 | $1.18M | Sell |
31,500
-234
| -0.7% | -$8.79K | 0.05% | 301 |
|
|
2013
Q2 | $853K | Buy |
+31,734
| New | +$853K | 0.05% | 286 |
|